Lasso peptide
Advantage:
Clear molecular structure;
Detectable content;
Clear mechanization;
Stably and efficiently;
The most ideal alternative direction of antibiotic;
The first choice of substitutes for colistin sulfate;
The nemesis of colibacillus and salmonella.
The effect of Lasso peptide:
Heat-resisting, acid and alkali-resisting, pepsin-resisting, trypsin-resisting;
Kill the common pathogenic bacteria efficiently, not killing lactic acid bacteria.
Table 1 The activity change after different treatment with Lasso peptide
|
Treatment conditions |
Treatment time |
Initial zone of inhibition |
Final zone of inhibition |
|
1000C (boil) |
2h |
22mm |
22mm |
|
1210C (high pressure) |
30min |
22mm |
22mm |
|
pH 2.0 |
4h |
22mm |
22mm |
|
pH 9.0 |
4h |
22mm |
22mm |
|
Digested by pepsin |
4h |
22mm |
22mm |
|
Digested by trypsin |
4h |
22mm |
22mm |
Table 2 The bacteriostatic effect on different bacterial strain with Lasso peptide
|
Bacterial strain |
Bacteriostatic effect |
Bacterial strain |
Bacteriostatic effect |
|
E. coli 078 |
++++ |
Streptococcus wildvirus ZQ180818 |
+ |
|
E. coli K99 |
++++ |
Clostridium perfringens GDMCC1.307 |
++++ |
|
E. coli SDJ211211 |
+++ |
Swine erysipelas Bacillus |
+++ |
|
Staphylococcus aureus GDMCC 1.142 |
+++ |
Lactobacillus casei CETC5276 |
× |
|
Salmonella wildvirus JM190223 |
++++ |
Nocardia asteroides GDMCC 4.141 |
+ |
|
Shigella GDMCC 1.1042 |
++++ |
Edwardsiella GDMCC 1.1025 |
++ |
|
Haemophilus parasuis |
++ |
Vibrio harveyi ATCC BAA-1117 |
++ |
|
Vibrio parahaemolyticus ATCC17802 |
++ |
Aeromonas hydrophila GDMCC 1.551 |
+++ |
| Company Name | Guangdong Drive Bio-tech Group Co., Ltd. | Country/Region | China |
| Business Type | Retailer | Company Size | 130 |
| Established | May 21, 2012 | ||
| Address | No. 4, Building 9, Dengtang Industrial Zone, Guangcong 10th Road, Baiyun District, Guangzhou City | ||
| Main Products | Lasso peptide；Gujing（Efficient mycotoxin-degrading enzymes）；Aquahemo (Hcy，Applied in aquatic production）；Aquahemo（Hb，Applied in aquatic production）；Quickhemo；Quickhemo (poultry)； Quickhemo (ruminant)；1% premix of layers / 0.5% premix of broilers； | ||
Guangdong Drive Bio-tech Group Co., Ltd. (hereinafter referred to as "Drive Group") was established in 2012. It is a national high-tech enterprise specializing in animal hematopoietic nutrition, a key enterprise in Guangdong Province, and entered the Beijing Stock Exchange in November 2021, becoming one of the first A-share listed companies on the Beijing Stock Exchange (,stock code: 920275). The production base is located in the scenic Baiyun District, Zhongluotan and Guangqing Industrial Park, Guangzhou.
The company has four wholly-owned subsidiaries, Guangzhou Suntheme Bio-tech Co., Ltd., Guangzhou Suntheme Feed Co., Ltd., Guangdong Suntheme Bio-tech Co., Ltd., and Guangzhou Saitaohua Bio-tech Co., Ltd. It has R&D institutions such as R&D platform of Guangzhou, national key R&D program pilot project promotion base and national key R&D Program demonstration, ect.
Drive Group has developed a new field of animal hematopoietic nutrition and obtained a number of national invention patents. The company focuses on the research and development, production, sales and service of animal hematopoietic nutrition feed additives, hematopoietic nutrition premixes, hematopoietic nutrition concentrates and other series of products in one. The company has been providing practical solutions for the farming industry to solve animal anemia and to increase efficiency and reduce costs.
Until now, Including the hematopoietic technology, the company has obtained 36 national patents , 1 international patent, 22 high-tech products and 3 famous brand products of Guangdong Province. It has also won the Science and Technology Promotion Development Award of the Chinese Academy of Sciences, Guangdong Provincial Specialized and Special New SMEs, Guangdong Provincial Innovative SMEs, Brand Innovation Award, Innovation Enterprise Award of Agriculture and Animal Husbandry Industry, and Outstanding Contribution Award of Animal Husbandry Development, Guangdong Feed Application Technology Innovation Award <Kapok Award>,Guangdong High-growth SME Award, Guangzhou Science and Technology Achievement Award, China Feed Additive Originality Product Award, Most Influential Green Animal Protection Product Award, China Agricultural "Golden Cotton Award", First place in the "Innovative Technology Award" in the livestock category, First prize in Chinese egg product contest. At the same time, it has won many awards and honors, such as Integrity Demonstration Enterprise in Guangdong Province, the Public Welfare Award for fighting COVID-19, the Caring Enterprise, and Annual synergy reduction service provider etc.
Hematopoietic products are the core technology products, covering pigs, poultry, aquatic animals and ruminants. It can increase the number of red blood cells and Hb of animals in a short period of time, which can effectively improve or solve the phenomenon of anemia commonly found in intensively reared animals, improve the breeding ability of animals, promote growth, significantly improve meat quality, and the quality and production efficiency of livestock products; Hematopoietic products can also improve animal immunity and increase the "infection threshold" of viruses, thus reducing susceptible animals and enhancing the ability to resist epidemics. In addition, hematopoietic products can play an important role in replacing antibiotics and reducing drug use, especially in replacing arsenic preparations, which can protect the environment and improve food safety.
Send Inquiry
